000 | 01557 a2200433 4500 | ||
---|---|---|---|
005 | 20250516214717.0 | ||
264 | 0 | _c20140716 | |
008 | 201407s 0 0 eng d | ||
022 | _a1555-9823 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShetty, Shreya J | |
245 | 0 | 0 |
_aComparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesothelioma. _h[electronic resource] |
260 |
_bThe American surgeon _cApr 2014 |
||
300 |
_a348-52 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHyperthermia, Induced |
650 | 0 | 4 |
_aLength of Stay _xstatistics & numerical data |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
650 | 0 | 4 | _aMesothelioma, Malignant |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMitomycin _xtherapeutic use |
650 | 0 | 4 |
_aPeritoneal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aBathla, Lokesh | |
700 | 1 | _aGovindarajan, Venkatesh | |
700 | 1 | _aThomas, Peter | |
700 | 1 | _aLoggie, Brian W | |
773 | 0 |
_tThe American surgeon _gvol. 80 _gno. 4 _gp. 348-52 |
|
999 |
_c23879064 _d23879064 |